Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/15/2014US8697716 Method of inhibiting C-KIT kinase
04/15/2014US8697715 Serine/threonine kinase inhibitors
04/15/2014US8697714 Quinazolinone based fluorogenic probes
04/15/2014US8697713 Pyrrolopyrimidines for pharmaceutical compositions
04/15/2014US8697712 Presentation of an antiviral pharmaceutical composition
04/15/2014US8697711 Inhibitors of bruton'S tyrosine kinase
04/15/2014US8697710 Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones
04/15/2014US8697709 Fused ring heteroaryl kinase inhibitors
04/15/2014US8697708 Azabenzothiazole compounds, compositions and methods of use
04/15/2014US8697706 Compounds for the treatment of hepatitis C
04/15/2014US8697705 Isoindolinone derivatives
04/15/2014US8697703 Piperazine derivatives for blocking Cav2.2 calcium channels
04/15/2014US8697702 Method of optimizing the treatment of Philadelphia-positive leukemia with imatinib mesylate
04/15/2014US8697701 Solid germicidal composition and disinfection method
04/15/2014US8697700 Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
04/15/2014US8697699 Imidazopyrazine SYK inhibitors
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/15/2014US8697697 Pyrazole derivatives as ERK inhibitors
04/15/2014US8697695 Pest control composition
04/15/2014US8697694 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
04/15/2014US8697693 Pharmaceutical compounds
04/15/2014US8697692 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
04/15/2014US8697691 Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective M1 agonists and methods of making and using same
04/15/2014US8697689 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
04/15/2014US8697688 Pyrrolobenzodiazepines used to treat proliferative diseases
04/15/2014US8697687 Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
04/15/2014US8697686 Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1H-3-benzazepine hydrochloride
04/15/2014US8697685 Chemical compounds
04/15/2014US8697684 Azetidinyl diamides as monoacylglycerol lipase inhibitors
04/15/2014US8697683 Azetidinyl diamides as monoacylglycerol lipase inhibitors
04/15/2014US8697682 Salts
04/15/2014US8697681 Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure
04/15/2014US8697680 Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis
04/15/2014US8697679 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
04/15/2014US8697678 Anaesthetic formulation
04/15/2014US8697677 Perhexiline for treating chronic heart failure
04/15/2014US8697676 Omega-3 fatty acid nutriceutical composition and optimization method
04/15/2014US8697675 Tenofovir alafenamide hemifumarate
04/15/2014US8697674 Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
04/15/2014US8697673 Bicyclic pyridinones
04/15/2014US8697671 Stabilized glycosaminoglycan preparations and related methods
04/15/2014US8697670 Compositions and methods of treating viral infections
04/15/2014US8697669 Folic acid-, vitamin B6- and vitamin B12-containing agents and the use thereof
04/15/2014US8697667 Cyclodextrin-modified polyamines for delivery of therapeutic molecules
04/15/2014US8697664 Targeted binding agents directed to PDGRF-alpha and uses thereof
04/15/2014US8697662 Methods for treating Kaposi sarcoma
04/15/2014US8697661 Use of spinosyns and spinosyn compositions against herpesviridae viral infections
04/15/2014US8697660 Compounds and compositions for treating infection
04/15/2014US8697659 Analogues of glycolipids useful as immunoadjuvants
04/15/2014US8697658 Glycoside compounds
04/15/2014US8697639 Compositions and methods for treating bacteria
04/15/2014US8697630 Method for lowering insulin resistance
04/15/2014US8697628 Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes
04/15/2014US8697627 Compositions and methods for treating alzheimer's disease
04/15/2014US8697602 Use of macrolides in pest control
04/15/2014US8697382 Method of identifying metallo-β-lactamase-producing bacteria
04/15/2014US8697379 Lysosomotropic inhibitors of acid ceramidase
04/15/2014US8697348 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
04/15/2014US8697172 Drink formula comprising fresh marine omega-3 oil and antioxidants
04/15/2014US8697137 Methods of using microspheres for active embolization
04/15/2014US8697133 Slow release compositions
04/15/2014US8697125 Tablet preparation without causing a tableting trouble
04/15/2014US8697124 Solid dosage form of coated bisphosphonate particles
04/15/2014US8697123 Medication on the basis of 3,3′-diindolylmethane (DIM) with high-bioavailability and its use in treatment of human hyperplastic and inflammatory diseases
04/15/2014US8697122 Formulation for retinoid-containing soft gelatin capsules
04/15/2014US8697115 Method of improving antioxidant status of an infant
04/15/2014US8697105 Injectable drug delivery formulation
04/15/2014US8697102 Compositions and methods for cell killing
04/15/2014US8697098 Polymer conjugated protein micelles
04/15/2014US8697097 Stable solid preparations
04/15/2014US8697094 Stable solid preparations
04/15/2014US8697077 Methods and compositions for treating autoimmune diseases
04/15/2014US8697064 Nitrogenated derivatives of pancratistatin
04/15/2014US8697061 Tumor specific oligosaccharide epitopes and use thereof
04/15/2014US8697055 Probiotic, lactic acid-producing bacteria
04/15/2014US8697045 Pegylated interleukin-10
04/15/2014US8697043 Odor suppression of volatile organic analgesic compounds and method of use
04/15/2014US8697033 Modified pyrazine derivatives and uses thereof
04/15/2014CA2764134C Compositions and methods for preventing sternal wound infections
04/15/2014CA2730478C Prodrugs of methyl hydrogen fumarate
04/15/2014CA2712005C Pharmaceutical solid state forms
04/15/2014CA2675733C Method for glycosylation of flavonoid compounds
04/15/2014CA2660376C Salts of benzimidazolyl pyridyl ethers and formulations thereof
04/15/2014CA2653355C Substituted phenyl methanone derivatives
04/15/2014CA2649556C Pharmaceutical solution formulations for pressurised metered dose inhalers
04/15/2014CA2642834C Oxa-steroids derivatives as selective progesterone receptor modulators
04/15/2014CA2642566C 17-phosphorous steroid derivatives useful as progesterone receptor modulators
04/15/2014CA2641216C Fixed-dose association of phytate and zinc
04/15/2014CA2637726C Anti-histamine compositions and use thereof
04/15/2014CA2623011C New formulation
04/15/2014CA2620183C Agents for preventing and treating disorders involving modulation of the ryr receptors
04/15/2014CA2615598C Compositions for treatment of systemic mastocytosis
04/15/2014CA2608319C Substituted spiro-compounds and the use thereof for producing medicaments
04/15/2014CA2578267C Methods for making retinoids and uses thereof
04/15/2014CA2575906C Compositions forming non-lamellar dispersions
04/15/2014CA2543858C Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
04/15/2014CA2527759C Use of s1p
04/15/2014CA2525130C Improved cytotoxic agents comprising new maytansinoids
04/15/2014CA2495498C Use of cgrp antagonist compounds for treatment of psoriasis
04/15/2014CA2399298C Use of il-18 inhibitors
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 7860